- Home
- Supplements
- Probiotics
- H. Pylori Infection
Probiotics for H. Pylori Infection
Probiotics do not eradicate H. pylori alone, but taken alongside antibiotic therapy they cut side effects like diarrhoea, improve course completion, and modestly raise eradication rates. This is one of the best-evidenced probiotic uses — as an adjunct to, never a replacement for, the antibiotic regimen.
Overview
No studies are currently linked to this pairing
This page reflects published clinical literature and conventional dosing rather than trial data attached to this concern in our library.
How It Works
Dosing & Protocol
| Context | Dose | Form | Timing |
|---|---|---|---|
| Most studied strain | 250-500 mg twice daily (about 5-10 billion CFU) | Saccharomyces boulardii | Throughout eradication therapy |
| Lactobacillus protocols | 1-10 billion CFU daily | L. reuteri, L. rhamnosus GG or multi-strain | With meals during therapy |
| Duration | Full antibiotic course plus 2-4 weeks after | - | Continuing afterwards supports microbiota recovery |
| Spacing | 2 hours from antibiotic doses | Applies to bacterial strains | S. boulardii does not require spacing |
Confirm eradication afterwards
A urea breath test or stool antigen test at least four weeks after finishing antibiotics, and two weeks off proton pump inhibitors, is the only way to know the infection has cleared.
Evidence
Adjunct, never a substitute
Good evidence for reducing antibiotic side effects and modestly improving eradication. No evidence that probiotics alone clear H. pylori.
Safety
Avoid live yeast with central venous catheters or immunosuppression
Saccharomyces boulardii has caused fungaemia in critically ill, immunocompromised and catheterised patients. Avoid it in those settings.
Interactions & Conflicts
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| Eradication antibiotics | low | Antibacterials kill bacterial probiotic strains | Separate by two hours, or use S. boulardii which is unaffected |
| Antifungal drugs | moderate | Kill Saccharomyces boulardii | Use a bacterial strain instead |
| Immunosuppressants and chemotherapy | high | Risk of systemic infection from live organisms | Avoid unless specialist-approved |
| Central venous catheters | high | Documented fungaemia with S. boulardii | Avoid live yeast preparations |
| Proton pump inhibitors | low | Standard part of eradication therapy; no adverse interaction | Continue as prescribed |
References
Frequently Asked Questions
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.